CLINICAL_TRIALS
trial_result
· 2019-07-15
Clinical Trial Update: Intrathecal Neostigmine for Prevention of PDPH [Phase 4]
Summary
Phase 4 clinical trial evaluating intrathecal neostigmine for prevention of post-dural puncture headache has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fayoum University Hospital | Conditions: Post-Dural Puncture Headache | Phase 4 | Status: COMPLETED